Home > News > Biotechnology companies learn how to attract more VC
March 17th, 2005
Biotechnology companies learn how to attract more VC
Christopher Anzalone, founder and CEO of The Benet Group in Washington, D.C., said the investment group looks for promising technology over all else. Nanotechnology looks particularly promising, with the federal government putting upward of a billion dollars into nanotech research annually.
But Bonsal said using public money to finance nanotech is probably premature. He cited NanoInk, a Chicago company formerly headed by Anzalone, which issued an initial public offering only to later withdraw it due to lack of interest. "There's capital," Anzalone said. "What's missing is good companies."
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015